Translational Oncology Research Center research group
One of the most difficult cancers to treat
A team of about 15 VUB researchers led by prof. Ilse Rooman is dedicating itself to pancreatic cancer research. Only 10% of patients survive 5 years after diagnosis and the number of diagnoses increases every year. In Prof. Dr. Ilse Rooman's Laboratory for Medical and Molecular Oncology, the research team discovered a new cell in the pancreas that offers opportunities for immunotherapy. The discovered cell is found in the pancreas of healthy people and bears a strong resemblance to the most aggressive pancreatic cancer cells. Understanding more about how the tumor develops will help improve detection and treatment.
Need for targeted treatment
Today, almost all patients are treated in the same way, regardless of the type of tumor. This is problematic because every tumor is different. Thanks to an investment by the VUB, we can analyze tumors in unprecedented detail using the high-tech COMET device. This opens up prospects for tailored treatments that give patients a better chance of recovery.
The device finally gives us a complete picture of pancreatic tumors. But the device alone cannot save lives. It is only through the analyses we perform with it that we can really make a difference for patients. But that is expensive. Each analysis costs an average of 2000 euros. With your support, we can make full use of the device and pave the way, step by step, toward targeted therapies.
COMET device to analyse tumors
Donate now and make a difference
Donate online or by bank transfer to the VUB's account number BE51 0013 6779 3562 stating GIFTFD18. Donations from 40 euros are tax deductible.
